So, it’s a huge unmet need. It’s 1 in 20, but, unfortunately, out of the 7,000 rare disease, 95 percent are without approved treatment,” said Tim Guilliams, co-founder and CEO of Healx, a company ...

Healx has dosed the first subject in the open-label Phase II INSPIRE-NF1 trial to assess the efficacy and safety of HLX-1502 ...

In an industry often driven by the relentless race to innovate, Healx is setting a new standard – one where technology meets ...

SMi Reports: AI HealthTech Company Healx, who raised $10m to advance drug discovery and treatments for rare diseases, are set to speak at the 8 th Annual Orphan Drugs and Rare Diseases Conference ...

With its Healnet platform, Healx pairs cutting-edge AI with industry-leading drug discovery and rare disease expertise to identify new uses for known compounds. The company now has over 20 ...